More about
Dmard
News
December 06, 2024
2 min watch
Save
VIDEO: ‘Highly treatable’ IgG4-related disease ‘rewarding’ to diagnose
In this video, John H. Stone, MD, MPH, professor of medicine at Harvard Medical School, the Edward A. Fox Chair in Medicine at Massachusetts General Hospital, discusses an important facet of IgG4-related disease other rheumatologists and providers should be aware of.
News
December 02, 2024
3 min watch
Save
VIDEO: ‘Provocative’ observational study assesses DMARD use in RA-ILD
WASHINGTON — In this video, Jeffrey A. Sparks, MD, MMSc, highlights an observational study investigating the impact of disease-modifying antirheumatic drugs on rheumatoid arthritis-associated interstitial lung disease.
News
November 06, 2024
2 min read
Save
Older, Asian patients less likely to receive b/ts DMARDs for rheumatoid arthritis
Patients with rheumatoid arthritis aged younger than 40 years are more than twice as likely to receive biologic or targeted synthetic disease-modifying anti-rheumatic drugs vs. older individuals, according to data.
Clinical Guidance
Psoriasis
Treatment Options
Oral Systemic Therapy for Psoriasis
Clinical Guidance
Rheumatoid Arthritis
Treatment Options
Conventional Synthetic Disease-Modifying Antirheumatic Drugs
Clinical Guidance
Rheumatoid Arthritis
Treatment Options
Corticosteroid Therapy
Clinical Guidance
Rheumatoid Arthritis
Treatment Guidelines
Pharmacotherapy and Management Guidelines
Clinical Guidance
Rheumatoid Arthritis
Presentation and Diagnosis
Diagnosis of Early Rheumatoid Arthritis
Clinical Guidance
Ankylosing Spondylitis
Assessment and Treatment
Assessment and Monitoring
Clinical Guidance
Ankylosing Spondylitis
Presentation and Diagnosis